Hormones and Cancer, Volume 127 in the Vitamins and Hormones series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors. Chapters in this new release include TARGETING STEROID HORMONE RECEPTORS FOR ANTI-CANCER THERAPY, FUNCTIONS OF DHEA IN RELATION TO BREAST CANCER, ROLE OF rhTSH IN MANAGEMENT OF DIFFERENTIATED THYROID CANCER, SEX HORMONES, INSULIN AND INSULIN-LIKE GROWTH FACTORS IN ENDOMETRIAL CANCER, HIGHER THYROID HORMONE LEVELS AND CANCER, LiFESTYLE IMPACT ON ESTROGEN, HORMONES AND CANCER, and much more.
Additional sections cover EPIGENETICS OF KISS1 IN REPRODUCTION AND CANCER, HISTOPATHOLOGICAL FEATURES OF ALDOSTERONE-PRODUCING LESIONS ACCORDING TO THEIR DIFFERENT SOMATIC GENETIC MUTATIONS, TARGETING EPIGENETIC EFFECTS OF ANDROGENS IN PROSTATE CANCER, Microbiome-Estrogen Connection in Cancer Risk, PREDICTING HYPGONADOTROPIC HYPOGONADISM PERSISTENCE IN MALE MACROPROLACTINOMA, and much more.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Editorial Board - p. iii 5. Copyright - p. iii 6. Former Editors - p. iii 7. Contributors - p. xi 8. About the editor - p. xv 9. Chapter One: Targeting steroid hormone receptors for anti-cancer therapy - p. 1 10. Chapter Two: Dehydroepiandrosterone (DHEA) in relation to breast cancer - p. 61 11. Chapter Three: Higher thyroid hormone levels and cancer - p. 99 12. Chapter Four: Histopathological features of aldosterone-producing lesions according to their different somatic genetic mutations - p. 125 13. Chapter Five: Targeting epigenetic effects of androgen-androgen receptor signaling in prostate cancer - p. 143 14. Chapter Six: Hypogonadism in men with prolactinoma: Diagnosis, treatment, and management of persistent hypogonadism - p. 185 15. Chapter Seven: The thyroid endocrine axis in breast cancer pathophysiology and prognosis - p. 203 16. Chapter Eight: B lymphoproliferative diseases: Effective treatment, inhibited progression, and potential cures through isoform-specific targeting of the prolactin receptor - p. 241 17. Chapter Nine: Targeting CDK4 and CDK6 in hormone-dependent cancers - p. 273 18. Chapter Ten: Hepcidin: A multifaceted hormone in iron homeostasis and tumor biology - p. 317
Hormones and Cancer, Volume 127 in the Vitamins and Hormones series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors. Chapters in this new release include TARGETING STEROID HORMONE RECEPTORS FOR ANTI-CANCER THERAPY, FUNCTIONS OF DHEA IN RELATION TO BREAST CANCER, ROLE OF rhTSH IN MANAGEMENT OF DIFFERENTIATED THYROID CANCER, SEX HORMONES, INSULIN AND INSULIN-LIKE GROWTH FACTORS IN ENDOMETRIAL CANCER, HIGHER THYROID HORMONE LEVELS AND CANCER, LiFESTYLE IMPACT ON ESTROGEN, HORMONES AND CANCER, and much more.
Additional sections cover EPIGENETICS OF KISS1 IN REPRODUCTION AND CANCER, HISTOPATHOLOGICAL FEATURES OF ALDOSTERONE-PRODUCING LESIONS ACCORDING TO THEIR DIFFERENT SOMATIC GENETIC MUTATIONS, TARGETING EPIGENETIC EFFECTS OF ANDROGENS IN PROSTATE CANCER, Microbiome-Estrogen Connection in Cancer Risk, PREDICTING HYPGONADOTROPIC HYPOGONADISM PERSISTENCE IN MALE MACROPROLACTINOMA, and much more.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Editorial Board - p. iii 5. Copyright - p. iii 6. Former Editors - p. iii 7. Contributors - p. xi 8. About the editor - p. xv 9. Chapter One: Targeting steroid hormone receptors for anti-cancer therapy - p. 1 10. Chapter Two: Dehydroepiandrosterone (DHEA) in relation to breast cancer - p. 61 11. Chapter Three: Higher thyroid hormone levels and cancer - p. 99 12. Chapter Four: Histopathological features of aldosterone-producing lesions according to their different somatic genetic mutations - p. 125 13. Chapter Five: Targeting epigenetic effects of androgen-androgen receptor signaling in prostate cancer - p. 143 14. Chapter Six: Hypogonadism in men with prolactinoma: Diagnosis, treatment, and management of persistent hypogonadism - p. 185 15. Chapter Seven: The thyroid endocrine axis in breast cancer pathophysiology and prognosis - p. 203 16. Chapter Eight: B lymphoproliferative diseases: Effective treatment, inhibited progression, and potential cures through isoform-specific targeting of the prolactin receptor - p. 241 17. Chapter Nine: Targeting CDK4 and CDK6 in hormone-dependent cancers - p. 273 18. Chapter Ten: Hepcidin: A multifaceted hormone in iron homeostasis and tumor biology - p. 317
